International Congress on Chemotherapy.
Smart
T
T
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000634:Aminoquinolines / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003218:Condylomata Acuminata / Q000150:complications / Q000188:drug therapy; D003457:Cryptosporidiosis / Q000150:complications / Q000188:drug therapy; D004337:Drug Carriers; D005092:Exonucleases / Q000008:administration & dosage / Q000627:therapeutic use; D017245:Foscarnet / Q000008:administration & dosage / Q000627:therapeutic use; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006801:Humans; D000077271:Imiquimod; D008081:Liposomes; D015575:Roxithromycin / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000998:Antiviral Agents; D004337:Drug Carriers; D017320:HIV Protease Inhibitors; D008081:Liposomes; D015575:Roxithromycin; D017245:Foscarnet; D005092:Exonucleases; D000077271:Imiquimod